KyungDong Pharm Co., Ltd. releases Sleepin Tablet, a non-psychotropic insomnia treatment, on July 1, 2017.

Sleepin Tablet is a product that improves insomnia by showing high affinity for the Histamine receptor, which plays an important role in regulating sleep and wakefulness.

It is an agent that is effective in maintaining continuous sleep by improving WASO (Wake after Sleep Onset) and TST (Total Sleep Time), improves sleep quality, and has no residual effects.

In addition, it is a proven product with a similar adverse reaction rate compared to placebo, so it is a non-psychotropic insomnia treatment that does not cause withdrawal symptoms or dependence even after long-term use.

It is expected that the overall growth of KyungDong Pharm Co., Ltd.'s psychotropic agent product line will be expected due to the launch of Sleepin Jeong.

- Product Information -

Product Name

Sleepin Jeong

Ingredient content

Doxepin hydrochloride 6.78mg per tablet (6mg as doxepin)

Appearance

green oval tablet

Indications

Short-term treatment for insomnia that is difficult to maintain sleep

Dosage and usage

Adults: 6mg once a day, 3mg once a day may be appropriate depending on the doctor's prescription

Seniors over 65 years of age: Recommended initial dosage: 3 mg once a day, as prescribed by a doctor

Can be administered up to 6mg per day

Should not be taken within 30 minutes before bedtime, but should not be taken within 3 hours after a meal.

How to save

Airtight container, stored at room temperature (1~30℃)

Packaging unit

30 tablets, 200 tablets

Insurance claim code

6481038707

* For further details, please refer to the product manual.